` CPIX (Cumberland Pharmaceuticals Inc) vs S&P 500 Comparison - Alpha Spread

CPIX
vs
S&P 500

Over the past 12 months, CPIX has significantly outperformed S&P 500, delivering a return of +133% compared to the S&P 500's +13% growth.

Stocks Performance
CPIX vs S&P 500

Loading
CPIX
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
CPIX vs S&P 500

Loading
CPIX
S&P 500
Difference
www.alphaspread.com

Performance By Year
CPIX vs S&P 500

Loading
CPIX
S&P 500
Add Stock

Competitors Performance
Cumberland Pharmaceuticals Inc vs Peers

S&P 500
CPIX
LLY
JNJ
NOVO B
ROG
Add Stock

Cumberland Pharmaceuticals Inc
Glance View

Market Cap
52.4m USD
Industry
Pharmaceuticals

Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the acquisition, development, and commercialization of prescription products. The company is headquartered in Nashville, Tennessee and currently employs 83 full-time employees. The company went IPO on 2009-08-11. Its portfolio of brands includes Acetadote injection, for the treatment of acetaminophen poisoning; Caldolor injection, for the treatment of pain and fever; Kristalose for oral solution, a prescription laxative, for the treatment of constipation; and Omeclamox-Pak for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease. Its brands also include RediTrex injection, for the treatment of active rheumatoid, juvenile idiopathic and severe psoriatic arthritis, as well as disabling psoriasis; Sancuso transdermal system, for the prevention of nausea and vomiting in patients receiving certain types of chemotherapy treatment; Vaprisol injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; and Vibativ injection.

CPIX Intrinsic Value
1.54 USD
Overvaluation 56%
Intrinsic Value
Price
Back to Top